Barclays Maintains Equal-Weight on HCA Healthcare, Lowers Price Target to $402

Benzinga Newsdesk www.benzinga.com Neutral 65.8%

Neg 0% Neu 65.8% Pos 0%

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers the price target from $427 to $402.